Thus, activation of integrins/FAK through an inside-out signaling by CAP1 knockdown in metastatic cancer cells has most likely directly activated ERK, which may subsequently inactivate GSK343. The gene discussed is PTK2; the disease is metastatic malignant neoplasm.